Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-12

Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Brain Stem Glioma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial results for antineoplaston therapy in brain stem glioma have been posted; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Brain Stem Gliomas | Phase 2 | Status: COMPLETED | Results posted: 2016-10-12